 |  | 
October 11, 2012 | | Regular Joe The vice president can be a top-notch political gunner, or a gaffe machine. Which one will show up to tonight’s debate? Matt Latimer sorts the many faces of Joltin’ Joe. HOORAY Good news from the Labor Department: the number of people seeking first-time unemployment fell this week, hitting a four-year low, according to figures reported on Thursday. There were 339,000 new jobless claims last week, a 30,000 decrease from last week’s figure of 369,000. It brought down the four-week moving average to 364,000, a decrease of 11,500 from the previous average. The claims figure is the lowest since February 2008 and undershot economists’ expectations of 370,000—and also represents a 63,000 drop in initial jobless claims from one year ago. Exclusive As the ex-coach begins a 30- to 60-year sentence, one of his lawyers tells Diane Dimond his strategy for getting a new trial: the defense didn’t have enough time to prepare the case. BOUNCE Mitt Romney’s been having a good week at least when it comes to the polls. The Republican challenger is up three points over President Obama in a Reuters/Ipsos tracking poll released on Thursday. Romney, who is now leading the president 47 percent to 44 percent among likely voters, appears to be riding a post debate bounce, erasing much of Obama’s lead in the last week. On Wednesday, Reuters’ polling data showed that Romney was up 45 to 44 percent. However, the president is maintaining a narrow lead in several of the key swing states. MENINGITIS We might be more understanding if the saying was “there’s a second time for everything.” Apparently, the compounding pharmacy that is linked to the meningitis outbreak that has killed 12 and infected 130 may have done this before. In 2004, the New England Compounding Center settled a lawsuit alleging it was responsible for the death of an 83-year-old man infected with a different form of meningitis, possibly by a shot produced by the company. To add to that, a drug company also owned by Ameridose was accused this year of mixing sterile and non-sterile products in the warehouse. And just this summer, an organization that links hospitals with drug suppliers cancelled a contract with Ameridose, saying their poor quality control “rose to a level of concern for patient safety.” | | 
GET The Cheat Sheet A speedy, smart summary of news and must-reads from across the Web. You'll love the featured original stories on politics, entertainment, and more from The Daily Beast's diverse group of contributors.  GET Culture Beast Weekly cultural recommendations from The Daily Beast.
| |
No comments:
Post a Comment